We have a late stage product in clinical trials; what is the full extent of the commercial opportunity? What is a viable commercialization strategy?

Many new ventures in the biotechnology and medical device sector are founded by a team of technologists that are highly competent and specialized in their respective fields, but do not necessarily have an extensive experience in building significant enterprises around their core inventions.

A client company in the biotechnology field had assembled a highly capable executive management team and had secured multiple rounds of financing, but no significant analysis had been carried out regarding the full commercial potential of the lead product, and viable strategies for commercialization. At the request of the Board of Directors, SI was engaged to critically analyze the market opportunity surrounding the company’s lead product, and develop one or more recommendations on viable commercialization strategies. SI systematically conducted a market and industry analysis, along with an internal analysis of the core strengths and weaknesses of the company to develop a detailed set of strategic options for the executive management. From that point forward, SI’s analysis was used for presentations to a wide range of audience, from investors, to Board of Directors, to potential corporate partners, as an objective and thorough analysis of the market landscape for the client company’s lead product and the company’s detailed commercialization strategy.